Looks like you’re on the UK site. Choose another location to see content specific to your location

Home Industry News Thermo Fisher Scientific technology used in new cancer studies

Thermo Fisher Scientific technology used in new cancer studies

18th September 2015

Thermo Fisher Scientific has shared data from two important scientific studies that have revealed key insights into cancer progression.

The company allied with the Biotech Research and Innovation Center (BRIC) at the University of Copenhagen to conduct the two landmark studies, published in the medical journal Cell, which shed light on how gene mutations can drive the progression of cancer.

Using Thermo Scientific Orbitrap mass spectrometry and next-generation sequencing, the researchers worked to discover how cancer attacks the protein networks controlling human cells.

They were able to uncover cancer-related changes to phosphorylation signaling networks, a breakthrough that could allow scientists to identify the effects of mutations on the function of protein pathways in cancer for individual patients, even if those mutations are very rare.

Ken Miller, vice-president of research product marketing for life sciences mass spectrometry at Thermo Fisher, said: "The studies highlight the importance of integrating proteomics with genomics in future cancer studies and underscores the value of the broad technological expertise within Thermo Fisher."

These represent some of the early results of a wider strategic collaboration between Thermo Fisher Scientific and the Linding Lab at BRIC.ADNFCR-8000103-ID-801800864-ADNFCR

We currently have 6 jobs available in Pharmacy industry, find your perfect one now.

Stay informed

Receive the latest industry news, Tips
and straight to your inbox.